New York, USA, Jan.20, 2021— GBI, a leading healthcare intelligence solutions provider, announced a deal with GPI focused on the distribution of global pricing data for drugs in the Asia Pacific and South America regions. GBI will use its global sales force and marketing channels to commercialize GPI’s global pricing data, which enable clients to make data-driven decisions and achieve market access excellence. GPI’s global pricing data solution GPI pulse™ is a trusted value, price, and access intelligence platform. GPI leverages the latest technology to combine multiple data streams in a way that provide unique insights in to the full biopharma market access journey.
Founded in 2002, GBI has built a portfolio of market intelligence solutions covering pharmaceuticals and medical devices. GBI’s value-added industry information, news, analytics, and data services enable its clients to make real-time, data-driven decisions.
GBI has offices in Shanghai, Beijing, and Washington D.C.
GPI is a market leader in analytics, insights and innovative solution for biopharma pricing and market access. GPI supports price decision-making and helps the life science industry achieve day to day operational improvement and market access excellence.